Key points are not available for this paper at this time.
Caution advised against extrapolating rat findings to patients; leaves open NE storage defects in human cardiomyopathy.
Repeated administration of large doses of isoproterenol to rats produced myocardial enlargement and a fall in blood pressure. A defect in storage of norepinephrine (NE) was manifested by a decrease in endogenous NE, unimpaired uptake of 3 H-NE, and an accelerated rate of loss of accumulated 3 H-NE. This accelerated loss of 3 H-NE was characterized by a more rapid disappearance of 3 H-NE from the granular or microsomal than from the supernatant NE fraction. The increased rate of loss of 3 H-NE could be reversed by treatment with a ganglionic blocking agent, chlorisondamine, by salt restriction and mercurial diuresis, and by withholding isoproterenol treatment for 7 days. The NE storage defect resembled that previously described in the hearts of rats made hypertensive by administration of desoxycorticosterone and NaCl. It is possible that the NE storage defect in the hearts of isoproterenol-treated rats is the result of a combination of changes in sympathetic nervous activity and altered neuronal electrolytes.
No takes yet. Share an insight, caveat, or question.
Mueller et al. (1968) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: